OrbiMed’s Eli Lilly LLY Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$263M	Hold	337,600	–	–	6.57%	3
2025 Q1	$279M	Hold	337,600	–	–	6.65%	4
2024 Q4	$261M	Hold	337,600	–	–	5.36%	4
2024 Q3	$299M	Hold	337,600	–	–	5.43%	3
2024 Q2	$306M	Sell	337,600 -23,200	-6%	-$21M	6.04%	2
2024 Q1	$281M	Sell	360,800 -4,600	-1%	-$3.58M	5.14%	2
2023 Q4	$213M	Buy	365,400 +179,400	+96%	+$105M	4.25%	3
2023 Q3	$99.9M	Hold	186,000	–	–	2.12%	10
2023 Q2	$87.2M	Hold	186,000	–	–	1.58%	20
2023 Q1	$63.9M	Buy	+186,000	New	+$63.9M	1.25%	23
2022 Q4	–	Hold	0	–	–	–	123
2022 Q3	–	Hold	0	–	–	–	135
2018 Q1	–	Sell	-2,288,000	Closed	-$193M	–	136
2017 Q4	$193M	Sell	2,288,000 -787,000	-26%	-$66.5M	2.44%	12
2017 Q3	$263M	Hold	3,075,000	–	–	2.51%	8
2017 Q2	$253M	Sell	3,075,000 -255,200	-8%	-$21M	2.65%	7
2017 Q1	$280M	Buy	3,330,200 +591,200	+22%	+$49.7M	3.18%	6
2016 Q4	$201M	Buy	2,739,000 +698,500	+34%	+$51.4M	2.57%	9
2016 Q3	$164M	Buy	2,040,500 +563,700	+38%	+$45.2M	1.87%	15
2016 Q2	$116M	Sell	1,476,800 -1,064,500	-42%	-$83.8M	1.21%	29
2016 Q1	$183M	Buy	2,541,300 +928,300	+58%	+$66.8M	1.93%	15
2015 Q4	$136M	Buy	1,613,000 +341,000	+27%	+$28.7M	1.23%	27
2015 Q3	$106M	Buy	+1,272,000	New	+$106M	1.07%	33
2014 Q4	–	Sell	-112,000	Closed	-$7.26M	–	123
2014 Q3	$7.26M	Sell	112,000 -288,000	-72%	-$18.7M	0.08%	98
2014 Q2	$24.9M	Sell	400,000 -143,000	-26%	-$8.89M	0.29%	56
2014 Q1	$32M	Buy	+543,000	New	+$32M	0.39%	47
2013 Q3	–	Hold	0	–	–	–	109
2013 Q2	–	Hold	0	–	–	–	112